Drug Shortage Report for TRILEPTAL 600 MG

Last updated on 2020-11-20 History
Report ID 128183
Drug Identification Number 02242069
Brand name TRILEPTAL 600 MG
Common or Proper name TRILEPTAL FCT 600 MG 5 X 10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) OXCARBAZEPINE
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 5 X 10
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-11-06
Actual start date
Estimated end date 2020-11-16
Actual end date 2020-11-19
Shortage status Resolved
Updated date 2020-11-20
Company comments Demand increase due to generic backorder. Limited stock available being allocated based on customer profile.
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-11-09 English Compare
v2 2020-11-09 French Compare
v3 2020-11-19 English Compare
v4 2020-11-19 French Compare
v5 2020-11-20 English Compare

Showing 1 to 5 of 5